X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24211) 24211
Newspaper Article (312) 312
Book Chapter (32) 32
Book / eBook (7) 7
Magazine Article (2) 2
Publication (2) 2
Dissertation (1) 1
Government Document (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16164) 16164
animals (9270) 9270
cell cycle (7543) 7543
cell biology (6171) 6171
oncology (6162) 6162
mice (5972) 5972
female (5949) 5949
cancer (5528) 5528
apoptosis (5383) 5383
proteins (5287) 5287
cyclin-dependent kinases (5270) 5270
kinases (4973) 4973
expression (4971) 4971
male (4952) 4952
phosphorylation (4783) 4783
biochemistry & molecular biology (4630) 4630
gene expression (4404) 4404
cell line, tumor (4306) 4306
cell proliferation (3806) 3806
research (3393) 3393
genetic aspects (2953) 2953
mutation (2944) 2944
signal transduction (2939) 2939
middle aged (2884) 2884
cyclin-dependent kinase inhibitor p21 - metabolism (2740) 2740
cyclin-dependent kinase inhibitor p21 (2713) 2713
tumors (2670) 2670
research article (2468) 2468
p53 (2435) 2435
tumor suppressor protein p53 - metabolism (2395) 2395
adult (2352) 2352
multidisciplinary sciences (2337) 2337
aged (2327) 2327
cyclin-dependent kinases - metabolism (2318) 2318
cyclin-dependent kinase inhibitor p16 - genetics (2265) 2265
analysis (2205) 2205
cyclin-dependent kinase inhibitor p21 - genetics (2195) 2195
cell growth (2144) 2144
genes (2122) 2122
activation (2095) 2095
gene expression regulation, neoplastic (2039) 2039
proliferation (2039) 2039
immunohistochemistry (2027) 2027
genetics & heredity (1988) 1988
medicine (1979) 1979
cells, cultured (1961) 1961
biology (1940) 1940
cell line (1873) 1873
tumor suppressor protein p53 - genetics (1797) 1797
protein (1795) 1795
health aspects (1759) 1759
growth (1757) 1757
deoxyribonucleic acid--dna (1737) 1737
gene (1708) 1708
apoptosis - drug effects (1672) 1672
physiological aspects (1661) 1661
p21 (1660) 1660
cell proliferation - drug effects (1646) 1646
science (1612) 1612
cell cycle proteins - metabolism (1595) 1595
cyclin-dependent kinase inhibitor p16 - metabolism (1586) 1586
cell division (1579) 1579
cyclins - metabolism (1566) 1566
cyclin-dependent kinase (1539) 1539
cell-cycle (1468) 1468
inhibition (1468) 1468
prognosis (1459) 1459
dna damage (1444) 1444
gene-expression (1425) 1425
breast cancer (1417) 1417
pathology (1414) 1414
transcription (1414) 1414
p16 (1410) 1410
blotting, western (1407) 1407
dna (1397) 1397
cells (1388) 1388
transfection (1388) 1388
down-regulation (1360) 1360
protein binding (1347) 1347
cyclin-dependent kinase inhibitor p27 (1341) 1341
molecular sequence data (1330) 1330
tumor cells, cultured (1310) 1310
dna methylation (1300) 1300
differentiation (1298) 1298
rats (1286) 1286
studies (1274) 1274
development and progression (1265) 1265
genetics (1262) 1262
p27 (1255) 1255
care and treatment (1241) 1241
cyclin-dependent kinases - genetics (1241) 1241
cell cycle proteins - genetics (1239) 1239
cyclins - genetics (1237) 1237
mice, knockout (1233) 1233
metastasis (1229) 1229
cyclin-dependent kinase inhibitor p27 - metabolism (1218) 1218
cyclin-dependent kinase 4 (1207) 1207
medicine, research & experimental (1190) 1190
flow cytometry (1179) 1179
polymerase chain reaction (1175) 1175
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (24504) 24504
Chinese (107) 107
Japanese (96) 96
German (26) 26
Russian (12) 12
Portuguese (8) 8
French (4) 4
Korean (3) 3
Spanish (3) 3
Norwegian (2) 2
Croatian (1) 1
Czech (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular cell, ISSN 1097-2765, 2014, Volume 53, Issue 2, pp. 193 - 208
Journal Article
Cancer discovery, ISSN 2159-8274, 04/2016, Volume 6, Issue 4, pp. 353 - 367
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2019, Volume 116, Issue 36, pp. 17990 - 18000
Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors are an established treatment in estrogen receptor-positive breast cancer and are currently in clinical development in melanoma, a tumor that exhibits high rates of CDK4 activation... 
PRMT5 | METHYLATION | MULTIDISCIPLINARY SCIENCES | VULNERABILITY | COMBINATION | acquired resistance | p53 | BREAST-CANCER | PALBOCICLIB | CDK4 | THERAPEUTIC TARGET | ARGININE METHYLTRANSFERASE | GROWTH | RESISTANCE | MDM4 | METHYLOSOME | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Cyclin-Dependent Kinase 4 - genetics | Humans | Protein-Arginine N-Methyltransferases - antagonists & inhibitors | Drug Resistance, Neoplasm | Tumor Suppressor Protein p53 - genetics | MCF-7 Cells | Melanoma - genetics | HEK293 Cells | Cell Cycle Proteins - genetics | Protein-Arginine N-Methyltransferases - genetics | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Melanoma - metabolism | Proto-Oncogene Proteins - metabolism | Cyclin-Dependent Kinase 2 - metabolism | Cell Cycle Proteins - metabolism | Cyclin-Dependent Kinase 6 - genetics | Tumor Suppressor Protein p53 - metabolism | Cyclin-Dependent Kinase 2 - genetics | Proto-Oncogene Proteins - genetics | Cyclin-Dependent Kinase 6 - metabolism | Melanoma - pathology | Cyclin-Dependent Kinase 4 - metabolism | Piperazines - pharmacology | Protein-Arginine N-Methyltransferases - metabolism | Melanoma - drug therapy | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | RNA | Tumor proteins | Analysis | Melanoma | GTP-binding protein | p53 Protein | Estrogens | Menopause | mRNA | Kinases | Cyclin-dependent kinase 4 | Proteins | Cell activation | Pancreatic carcinoma | Arginine | Inhibition | Pancreas | Esophageal carcinoma | Splicing | Cyclin-dependent kinases | Protein arginine methyltransferase | Breast cancer | Esophagus | Cyclin-dependent kinase 2 | Sensitivity | Inhibitors | Tumor suppressor genes | Tumors | Biological Sciences | PNAS Plus
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 25 - 35
Summary Background Palbociclib (PD-0332991) is an oral, small-molecule inhibitor of cyclin-dependent kinases (CDKs... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | EXEMESTANE | ONCOLOGY | CELL-CYCLE | POSTMENOPAUSAL WOMEN | HER2 | PLUS | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Piperazines - administration & dosage | Triazoles - administration & dosage | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptors, Estrogen - analysis | Molecular Targeted Therapy | North America | Nitriles - administration & dosage | Breast Neoplasms - enzymology | Time Factors | Postmenopause | Female | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Republic of Korea | Aromatase Inhibitors - administration & dosage | Pyridines - administration & dosage | Drug Administration Schedule | Administration, Oral | Biomarkers, Tumor - analysis | Europe | Proportional Hazards Models | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Treatment Outcome | Cyclin-Dependent Kinase 6 - metabolism | Cyclin-Dependent Kinase 4 - metabolism | Breast Neoplasms - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Breast Neoplasms - genetics | Cyclin D1 - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Intention to Treat Analysis | South Africa | Aged | Biomarkers, Tumor - genetics | Receptor, ErbB-2 - analysis | Antimitotic agents | Care and treatment | Oncology, Experimental | Estrogen | Breast cancer | Research | Antineoplastic agents | Phosphotransferases | Cancer
Journal Article
Nature (London), ISSN 1476-4687, 2017, Volume 548, Issue 7668, pp. 471 - 475
Cyclin-dependent kinases 4 and 6 (CDK4/6) are fundamental drivers of the cell cycle and are required for the initiation and progression of various malignancies(1,2... 
BREAST-CANCER | CELLS | METHYLATION | MULTIDISCIPLINARY SCIENCES | SENESCENCE | EXPRESSION | REQUIREMENT | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Viruses - genetics | Breast Neoplasms - immunology | Humans | Transcriptome | T-Lymphocytes, Regulatory - immunology | T-Lymphocytes, Regulatory - cytology | Female | Biological Mimicry - drug effects | Phosphorylation - drug effects | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Disease Models, Animal | Viruses - drug effects | Viruses - immunology | Antigen Presentation - immunology | Breast Neoplasms - drug therapy | T-Lymphocytes, Regulatory - drug effects | Animals | Breast Neoplasms - genetics | Repressor Proteins - biosynthesis | Signal Transduction - drug effects | Breast Neoplasms - pathology | Cell Cycle Checkpoints - drug effects | Protein Kinase Inhibitors - therapeutic use | RNA, Double-Stranded - genetics | Cell Line, Tumor | Interferons - metabolism | Antigen Presentation - drug effects | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Oncology, Experimental | Cancer cells | Physiological aspects | Research | Protein kinases | Immunity | Cyclins | Cancer | Cell proliferation | Flow cytometry | Animal models | Phosphorylation | Senescence | Peptides | Genomics | Immune clearance | Cytotoxicity | Lymphocytes T | Genomes | Kinases | Cancer therapies | Cyclin-dependent kinase 4 | E2F protein | Breast carcinoma | Cell growth | Lymphocytes | New combinations | Cell cycle | Inhibition | Deoxyribonucleic acid--DNA | Immune system | Antigen presentation | Medical research | Immune response | Immunoregulation | Intracellular levels | Double-stranded RNA | Breast cancer | Pharmacology | Gene expression | Ribonucleic acid--RNA | Inhibitors | Immune checkpoint | Immunogenicity | DNA methyltransferase | Interferon | Retinoblastoma | Tumors | Apoptosis
Journal Article
Biochemical and biophysical research communications, ISSN 0006-291X, 04/2017, Volume 486, Issue 2, pp. 385 - 390
TEA domain transcription factor 4 (TEAD4), which has critical functions in the process of embryonic development, is expressed in various cancers. However, the... 
TEA domain transcription factor 4 | Human oral squamous cell carcinoma | Yes-associated protein (YAP) | TARGET | BIOMARKER | BIOCHEMISTRY & MOLECULAR BIOLOGY | HIPPO PATHWAY | YAP | FAMILY | BIOPHYSICS | DNA | PROGNOSTIC MARKER | EXPRESSION | RNA, Small Interfering - genetics | Cell Proliferation | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Cyclin E - genetics | Cyclin-Dependent Kinase Inhibitor p27 - metabolism | Cell Nucleus - metabolism | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Muscle Proteins - antagonists & inhibitors | Transcription, Genetic | Mouth Neoplasms - genetics | Cyclin-Dependent Kinase 2 - metabolism | DNA-Binding Proteins - antagonists & inhibitors | Signal Transduction | Cyclin-Dependent Kinase 2 - genetics | Cyclin-Dependent Kinase 6 - metabolism | Cyclin-Dependent Kinase 4 - metabolism | Muscle Proteins - genetics | Cell Nucleus - genetics | Cyclin D1 - genetics | Mouth Neoplasms - surgery | Cell Line, Tumor | RNA, Small Interfering - metabolism | Cyclin D1 - metabolism | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Cyclin-Dependent Kinase 4 - genetics | Gene Expression Regulation, Neoplastic | Carcinoma, Squamous Cell - surgery | Mouth Neoplasms - metabolism | Phosphoproteins - metabolism | DNA-Binding Proteins - metabolism | Cyclin-Dependent Kinase Inhibitor p21 - genetics | Muscle Proteins - metabolism | G1 Phase Cell Cycle Checkpoints | Female | Cyclin-Dependent Kinase 6 - genetics | Transcription Factors - antagonists & inhibitors | Phosphoproteins - genetics | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Transcription Factors - metabolism | Adaptor Proteins, Signal Transducing - genetics | Mouth Neoplasms - pathology | Aged | Cyclin E - metabolism | Adaptor Proteins, Signal Transducing - metabolism | Cyclin-Dependent Kinase Inhibitor p27 - genetics | Immunohistochemistry | Medical colleges | Embryonic development | Squamous cell carcinoma | Growth | Analysis | DNA polymerases | Genetic transcription | Health aspects | Development and progression | TRANSCRIPTION FACTORS | CHAIN REACTIONS | BIOLOGICAL MARKERS | CELL PROLIFERATION | CELL CYCLE | INTERACTIONS | 60 APPLIED LIFE SCIENCES | PLANT GROWTH
Journal Article
Epigenetics, ISSN 1559-2294, 11/2010, Volume 5, Issue 8, pp. 685 - 690
The INK4b-ARF-INK4a locus encodes for two cyclin-dependent kinase inhibitors, p15 INK4b and p16 INK4a and a regulator of the p53 pathway, ARF... 
Binding | Proteins | Landes | Calcium | Bioscience | Biology | Cell | Cycle | Cancer | Organogenesis | ANRIL | DNA methylation | Polycomb | Histone demethylases | Senescence | ARF | INK4A-ARF LOCUS | EMBRYONIC FIBROBLASTS | histone demethylases | BIOCHEMISTRY & MOLECULAR BIOLOGY | METHYLATED HISTONE H3 | METHYLTRANSFERASE ACTIVITY | CELL-PROLIFERATION | senescence | polycomb | GENETICS & HEREDITY | TUMOR-SUPPRESSOR | p16(INK4a) | p15(INK4b) | TARGETED DELETION | DEMETHYLASE JMJD3 CONTRIBUTES | POLYCOMB-GROUP | GENOME-WIDE ASSOCIATION | Chromatin - metabolism | Proto-Oncogene Proteins c-mdm2 - genetics | Cyclin-Dependent Kinase 4 - genetics | Diabetes Mellitus, Type 2 - genetics | Epigenesis, Genetic | Humans | Diabetes Mellitus, Type 2 - metabolism | Genetic Loci | Cardiovascular Diseases - genetics | Cyclin-Dependent Kinase Inhibitor p15 - biosynthesis | RNA, Untranslated - genetics | Tumor Suppressor Protein p53 - genetics | Cyclin-Dependent Kinase Inhibitor p15 - genetics | ADP-Ribosylation Factors - biosynthesis | DNA Modification Methylases | Cyclin-Dependent Kinase Inhibitor p16 - biosynthesis | G1 Phase - genetics | ADP-Ribosylation Factors - genetics | Proto-Oncogene Proteins c-mdm2 - metabolism | Repressor Proteins - metabolism | Cardiovascular Diseases - metabolism | Cyclin-Dependent Kinase 6 - genetics | Tumor Suppressor Protein p53 - metabolism | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Repressor Proteins - genetics | Cyclin-Dependent Kinase 6 - metabolism | Signal Transduction - genetics | Polycomb-Group Proteins | Cyclin-Dependent Kinase 4 - metabolism | Animals | Histone Demethylases | RNA, Untranslated - biosynthesis | Alzheimer Disease - metabolism | Transcription, Genetic - genetics | Alzheimer Disease - genetics | Chromatin - genetics | p16INK4a | Point-of-View | p15INK4b
Journal Article
The Journal of experimental medicine, ISSN 0022-1007, 2014, Volume 211, Issue 7, pp. 1379 - 1391
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 2017, Volume 379, pp. 229 - 235
Journal Article
Clinical cancer research, ISSN 1078-0432, 06/2017, Volume 23, Issue 11, pp. 2856 - 2868
Purpose: Anaplastic lymphoma kinase (ALK) is the most frequently mutated oncogene in the pediatric cancer neuroblastoma... 
MELANOMA | THERAPY | MEK INHIBITION | ONCOLOGY | PATHWAY | KINASE | CRIZOTINIB | RESISTANCE | COMBINATION | COMBINED BRAF | ACTIVATING MUTATIONS | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Small Molecule Libraries - administration & dosage | Cyclin-Dependent Kinase 4 - genetics | Humans | Purines - administration & dosage | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Neuroblastoma - pathology | Aminopyridines - administration & dosage | Pyrimidines - administration & dosage | Neuroblastoma - genetics | Cyclin-Dependent Kinase 6 - genetics | Drug Synergism | Xenograft Model Antitumor Assays | Animals | Receptor Protein-Tyrosine Kinases - genetics | Signal Transduction - drug effects | Retinoblastoma Protein - genetics | Neuroblastoma - drug therapy | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mutation | Cyclin D - genetics | Sulfones - administration & dosage | Therapy | Pediatrics | Biotechnology | Animal models | Toxicity | Clinical trials | Cytotoxicity | Neuroblastoma | Drug development | Drug screening | Cyclin-dependent kinase 4 | Anticancer properties | Cell activation | Cell cycle | Xenografts | Biocompatibility | Cyclin D | Inhibition | Children | Protein-tyrosine kinase | Cyclin-dependent kinases | Caspase | Pharmacology | Lymphoma | Signaling | Inhibitors | Experimental design | Cell death | Antitumor activity | Pharmacokinetics | Viability | Cancer
Journal Article
Molecular and Cellular Biology, ISSN 0270-7306, 10/2013, Volume 33, Issue 19, pp. 3780 - 3794
Journal Article
Nature (London), ISSN 1476-4687, 2016, Volume 534, Issue 7605, pp. 55 - 62
Somatic mutations have been extensively characterized in breast cancer, but the effects of these genetic alterations on the proteomic landscape remain poorly understood... 
PATHWAYS | HETEROGENEITY | PIK3CA MUTATIONS | PHOSPHORYLATION | MULTIDISCIPLINARY SCIENCES | GENES | BIOLOGY | RECEPTOR | EXPRESSION | SIGNATURE | REVEALS | Protein Kinases - metabolism | Focal Adhesion Kinase 1 - genetics | Receptor, Epidermal Growth Factor - genetics | Protein Kinases - genetics | Cyclin-Dependent Kinases - metabolism | Receptor, ErbB-2 - genetics | Receptors, G-Protein-Coupled - metabolism | Genomics | Humans | Gene Expression Regulation, Neoplastic | Receptor, ErbB-2 - metabolism | Phosphoproteins - metabolism | Receptor-Interacting Protein Serine-Threonine Kinase 2 - genetics | Tumor Suppressor Protein p53 - genetics | Breast Neoplasms - metabolism | Receptor-Interacting Protein Serine-Threonine Kinase 2 - metabolism | Breast Neoplasms - enzymology | Receptor, Epidermal Growth Factor - metabolism | Phosphoproteins - analysis | Mass Spectrometry | src-Family Kinases - metabolism | Female | Cyclin-Dependent Kinases - genetics | Focal Adhesion Kinase 1 - metabolism | Chromosomes, Human, Pair 5 - genetics | Breast Neoplasms - classification | Chromosome Deletion | p21-Activated Kinases - genetics | Signal Transduction | Molecular Sequence Annotation | Calcium-Binding Proteins - deficiency | Phosphoproteins - genetics | Mutation - genetics | S-Phase Kinase-Associated Proteins - metabolism | p21-Activated Kinases - metabolism | Phosphatidylinositol 3-Kinases - genetics | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Proteomics | S-Phase Kinase-Associated Proteins - genetics | Receptors, G-Protein-Coupled - genetics | src-Family Kinases - genetics | Calcium-Binding Proteins - genetics | Breast cancer | Genetic aspects | Research | Oncology, Experimental | Cancer | Physiological aspects | Methods | Mutation (Biology) | Proteins | Gene amplification | Peptides | Protein expression | Genomes | Mutation | Kinases | Deoxyribonucleic acid--DNA | Tumors
Journal Article